As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
A crucial step in drug development, bioassay development can take from three months to a year to accomplish. Time, personnel, and budget resources along with reagent, drug lot, and cell-line ...
EMERYVILLE, Calif., May 06, 2025--(BUSINESS WIRE)--Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of ...
A major challenge preventing transformative gene therapies from reaching patients is the lack of fit-for purpose potency assays, which are some of the most important assays in an analytical package ...
Bioassays are critical for determining drug substance and drug product potency, which is why it is important to understand the fundamentals of developing an effective bioassay. A bioassay measures ...
The cancer therapy landscape is changing rapidly as CAR T cells achieve more regulatory approvals and gain traction in the clinic. The first approved CAR T-cell therapy, which treats acute ...
Developing bioassay methods requires a new approach for cell and gene therapy drug development. As cell-based methods continue to evolve in support of gene therapies to assess product potency through ...
HOUSTON, Dec. 3, 2025 /PRNewswire/ -- Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback